Drug Discrimination

Create: 03/29/2019

Expired Date:	never
Category:	Immunoglobulins [Chemical]
Message:	The relative abuse liability of a novel drug is an important consideration in the development of that drug as a new medication. At Creative Biolabs, we utilize a well-established and valuable technique to assess the potential abuse liability of drug candidates, that is the drug discrimination (DD). Moreover, the paradigm can also be used to elucidate the pharmacological mechanisms and to assess the pharmacodynamic profiles of novel compounds. https://www.creative-biolabs.com/drug-discovery/therapeutics/drug-discrimination.htm.






City:	Shirley[US]
Location:

Feb 01 2023	GVB⁺⁺ (with Ca and Mg) Buffer	229
Feb 01 2023	Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)	222
Aug 29 2019	Elevated Plus Maze Test	411
Aug 29 2019	Tail Suspension Test	421
Aug 29 2019	Forced Swim Test	401
Aug 29 2019	Three Chamber Social Test	341
Aug 29 2019	Rodent Social Behavior Tests	350
Aug 29 2019	Passive Avoidance Test	358
Aug 29 2019	Rodent Behavioral Tests for Cognition	347
Aug 29 2019	Magic™ Humanized IL-17A Immune Checkpoint Knock-In Mice	349